Clinical trial Recruiting at 3 sites Observational Ages 25 to 35

Imaging lung health in young adults using Hyperpolarized 129Xe MRI

Official title: Hyperpolarized 129Xe MRI to Identify Structural Determinants of Low Lung Function and Respiratory Symptoms in Young Adults From the Lung Health Cohort

Run by University of Kansas Medical Center · NCT05766384 · Data updated 2026-11-12

This study is testing a special type of MRI to see how healthy the lungs are in young adults and to find any early signs of lung problems.

Quick facts

Study typeObservational
Ages25 Years to 35 Years
SexAll
Enrollment260 (estimated)
SponsorUniversity of Kansas Medical Center
Academic / other
Locations6 sites (Chicago, Illinois and 5 other locations)
StatusRecruiting
StartedNovember 30, 2023
Main results expectedMarch 31, 2027
Study endsMarch 31, 2027
Registry record updatedMay 1, 2026
Trial IDNCT05766384 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are young adults enrolled in the American Lung Association Lung Health Cohort who have had recent CT imaging.

Probably not a fit

Patients with implanted electronic devices, those who are pregnant or breastfeeding, or individuals with low oxygen saturation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study involves a subset of young adults from the American Lung Association Lung Health Cohort who will undergo imaging with Hyperpolarized 129Xe MRI. The goal is to assess lung structure and function, providing insights into lung health and identifying early abnormalities that could lead to chronic lung diseases. Participants must have previously completed CT imaging as part of the Lung Health Cohort within the last two years. The study aims to enhance understanding of lung health through advanced imaging techniques.

Why it matters

Potential benefit: If successful, this study could lead to improved early detection and understanding of lung abnormalities, potentially preventing chronic lung diseases.

How similar studies have gone: Other studies using advanced imaging techniques have shown promise in understanding lung health, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Is enrolled in the American Lung Association Lung Health Cohort Study.
* Has completed CT imaging for the LHC study within 2 years of the scheduled Xe-MRI date.

Exclusion Criteria:

* Pacemaker, internal defibrillator or other implanted electronic devices or any standard MRI contraindications (e.g., claustrophobia, \> 140 cm shoulder circumference, dependent on weight distribution).
* Is pregnant or breastfeeding
* Oxygen saturation (SpO2) \<88% on room air or with supplemental oxygen.

Where it's running

  • University of Iowa
    Iowa City, Iowa, United States
    Recruiting
  • University of Kansas Medical Center
    Kansas City, Kansas, United States
    Recruiting
  • Duke University
    Durham, North Carolina, United States
    Recruiting
  • University of Illinois-Chicago
    Chicago, Illinois, United States
    Not yet recruiting
  • Baylor College of Medicine
    Houston, Texas, United States
    Not yet recruiting
  • MD Anderson Cancer Center
    Houston, Texas, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.